Cargando…
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
BACKGROUND: The safety and immunogenicity of the coadministration of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV), quadrivalent split-virion inactivated influenza vaccine (IIV4), and 23-valent pneumococcal polysaccharide vaccine (PPV23) in adults in China is unknown. METHODS: In this ope...
Autores principales: | Chen, Haiping, Huang, Zhuoying, Chang, Shaoying, Hu, Mei, Lu, Qingbin, Zhang, Yuntao, Wang, Hui, Xiao, Yanhui, Ge, Yonghong, Zou, Yong, Cui, Fuqiang, Han, Shasha, Zhang, Min, Wang, Shengyi, Zhu, Xiaoping, Zhang, Biao, Li, Zhi, Ren, Jia, Chen, Xiao, Ma, Rui, Zhang, Lei, Guo, Xue, Luo, Linyun, Sun, Xiaodong, Yang, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334936/ https://www.ncbi.nlm.nih.gov/pubmed/35931636 http://dx.doi.org/10.1016/j.vaccine.2022.07.033 |
Ejemplares similares
-
Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
por: Wang, Chao, et al.
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination
por: Hosseinzadeh, Rezvan, et al.
Publicado: (2022) -
Abducense nerve palsy following BBIBP-CorV (Sinopharm) COVID-19 vaccine
por: Khalili, M.R., et al.
Publicado: (2022) -
Cord blood antibodies following BBIBP‐CorV (Sinopharm) vaccination during pregnancy
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2023)